PHBI
Pharmagreen Biotech Inc.
Price Chart
Latest Quote
$0.00
-0.00 (-10.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 2,014 |
Stock Information
| Shares Outstanding | 691.35M |
| Total Debt | $352K |
| Cash Equivalents | $906 |
| Revenue | $3K |
| Net Income | $-226K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $622K |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $968K |
| Sales | $3K |
| Income | $-226K |
| Book/sh | $-0.00 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.04 |
Returns & Margins
| ROA | -139.13% |
| Gross Margin | 44.90% |
| Operating Margin | -7420.17% |
Ownership
| Insider Ownership | 12.77% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 207.27 |
| P/B | -0.22 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 41.86 |
| ATR | 0.0002 |
| Shares Float | 625.17M |
| Volatility | 1.72 |
| Rel Volume | 0.01 |
Performance History
| Week | -10.00% |
| Month | +0.00% |
| Quarter | -43.75% |
| 6 Months | -68.97% |
| YTD | -62.50% |
| Year | -6.25% |
| 3 Years | -69.28% |
| 5 Years | -96.44% |
| 10 Years | -99.85% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.00 | 2,183 |
| 2026-06-17 | $0.00 | 0 |
| 2026-06-16 | $0.00 | 0 |
| 2026-06-15 | $0.00 | 69,259 |
| 2026-06-12 | $0.00 | 217,542 |
| 2026-06-11 | $0.00 | 76,014 |
| 2026-06-10 | $0.00 | 3,014 |
| 2026-06-09 | $0.00 | 925,465 |
| 2026-06-08 | $0.00 | 500,000 |
| 2026-06-05 | $0.00 | 425,660 |
| 2026-06-04 | $0.00 | 655,270 |
| 2026-06-03 | $0.00 | 785,198 |
| 2026-06-02 | $0.00 | 11,014 |
| 2026-06-01 | $0.00 | 72,527 |
| 2026-05-29 | $0.00 | 0 |
| 2026-05-28 | $0.00 | 1,062,863 |
| 2026-05-27 | $0.00 | 0 |
| 2026-05-26 | $0.00 | 380,911 |
| 2026-05-22 | $0.00 | 2,357,319 |
| 2026-05-21 | $0.00 | 100,625 |
| 2026-05-20 | $0.00 | 4,850,067 |
| 2026-05-19 | $0.00 | 9,932,208 |
About Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on PHBI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2022-09-30 | 2021-09-30 |
|---|---|---|
| Revenue | ||
| Total Revenue | $0 | $0 |
| Operating Revenue | $0 | $0 |
| Expenses | ||
| Interest Expense | $47,245 | $768,978 |
| Total Expenses | $1,069,748 | $752,729 |
| Other Income Expense | $241,488 | $-3,010,517 |
| Other Non Operating Income Expenses | $57,613 | $237,940 |
| Net Non Operating Interest Income Expense | $-47,245 | $-768,978 |
| Interest Expense Non Operating | $47,245 | $768,978 |
| Operating Expense | $1,069,748 | $752,729 |
| General And Administrative Expense | $1,069,748 | $752,729 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-875,478 | $-4,532,071 |
| Net Interest Income | $-47,245 | $-768,978 |
| Normalized Income | $-1,059,353 | $-1,283,614 |
| Net Income From Continuing And Discontinued Operation | $-875,478 | $-4,532,071 |
| Net Income Common Stockholders | $-875,478 | $-4,532,071 |
| Net Income | $-875,478 | $-4,532,071 |
| Net Income Including Noncontrolling Interests | $-875,505 | $-4,532,224 |
| Net Income Continuous Operations | $-875,505 | $-4,532,224 |
| Pretax Income | $-875,505 | $-4,532,224 |
| Operating Income | $-1,069,748 | $-752,729 |
| Special Income Charges | - | $0 |
| Per Share | ||
| Diluted EPS | $-0.00 | $-0.02 |
| Basic EPS | $-0.00 | $-0.02 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,012,135 | $-514,789 |
| Total Unusual Items | $183,875 | $-3,248,457 |
| Total Unusual Items Excluding Goodwill | $183,875 | $-3,248,457 |
| EBITDA (Bullshit earnings) | $-828,260 | $-3,763,246 |
| EBIT | $-828,260 | $-3,763,246 |
| Diluted Average Shares | $403,732,631 | $293,706,579 |
| Basic Average Shares | $403,732,631 | $293,706,579 |
| Diluted NI Availto Com Stockholders | $-875,478 | $-4,532,071 |
| Minority Interests | $27 | $153 |
| Gain On Sale Of Security | $183,875 | $-3,248,457 |
| Selling General And Administration | $1,069,748 | $752,729 |
| Other Gand A | $1,053,273 | $733,296 |
| Salaries And Wages | $16,475 | $19,433 |
| Other Special Charges | - | $-237,940 |
| Impairment Of Capital Assets | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2022-09-30 | 2021-09-30 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-1,775,964 | $-1,646,042 |
| Total Assets | $208,971 | $373,081 |
| Total Non Current Assets | $0 | $0 |
| Current Assets | $208,971 | $373,081 |
| Prepaid Assets | $200,572 | $347,491 |
| Receivables | $383 | $290 |
| Accounts Receivable | $383 | $290 |
| Cash Cash Equivalents And Short Term Investments | $8,016 | $25,300 |
| Cash And Cash Equivalents | $8,016 | $25,300 |
| Cash Financial | $8,016 | $25,300 |
| Debt | ||
| Net Debt | $330,572 | $244,900 |
| Total Debt | $338,588 | $270,200 |
| Long Term Debt And Capital Lease Obligation | $119,473 | $39,366 |
| Long Term Debt | $119,473 | $39,366 |
| Current Debt And Capital Lease Obligation | $219,115 | $230,834 |
| Current Debt | $219,115 | $230,834 |
| Other Current Borrowings | $179,115 | $190,834 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $2,031,620 | $2,065,781 |
| Total Non Current Liabilities Net Minority Interest | $119,473 | $39,366 |
| Current Liabilities | $1,912,147 | $2,026,415 |
| Other Current Liabilities | $271,394 | $472,003 |
| Current Deferred Liabilities | $54,847 | $59,122 |
| Current Notes Payable | $40,000 | $40,000 |
| Payables And Accrued Expenses | $1,366,791 | $1,264,456 |
| Interest Payable | $79,906 | $79,586 |
| Payables | $1,286,885 | $1,184,870 |
| Accounts Payable | $644,970 | $579,851 |
| Equity | ||
| Common Stock Equity | $-1,775,974 | $-1,646,052 |
| Preferred Stock Equity | $10 | $10 |
| Total Equity Gross Minority Interest | $-1,822,649 | $-1,692,700 |
| Stockholders Equity | $-1,775,964 | $-1,646,042 |
| Other Equity Interest | $1,130 | - |
| Gains Losses Not Affecting Retained Earnings | $93,753 | $-8,378 |
| Other Equity Adjustments | $93,753 | $-8,378 |
| Retained Earnings | $-12,574,895 | $-11,699,417 |
| Other | ||
| Ordinary Shares Number | $442,260,969 | $381,171,269 |
| Share Issued | $442,260,969 | $381,171,269 |
| Tangible Book Value | $-1,775,974 | $-1,646,052 |
| Invested Capital | $-1,437,386 | $-1,375,852 |
| Working Capital | $-1,703,176 | $-1,653,334 |
| Total Capitalization | $-1,656,491 | $-1,606,676 |
| Minority Interest | $-46,685 | $-46,658 |
| Additional Paid In Capital | $10,261,777 | $9,680,572 |
| Capital Stock | $442,271 | $381,181 |
| Common Stock | $442,261 | $381,171 |
| Preferred Stock | $10 | $10 |
| Current Accrued Expenses | $79,906 | $79,586 |
| Dueto Related Parties Current | $641,915 | $605,019 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2022-09-30 | 2021-09-30 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $-426,568 | $-206,081 |
| Operating Activities | ||
| Operating Cash Flow | $-426,568 | $-206,081 |
| Cash Flow From Continuing Operating Activities | $-426,568 | $-206,081 |
| Operating Gains Losses | $-215,620 | $3,019,182 |
| Financing Activities | ||
| Issuance Of Capital Stock | $187,000 | $267,736 |
| Financing Cash Flow | $313,708 | $257,498 |
| Cash Flow From Continuing Financing Activities | $313,708 | $257,498 |
| Net Preferred Stock Issuance | $0 | $10 |
| Preferred Stock Issuance | $0 | $10 |
| Net Common Stock Issuance | $187,000 | $267,726 |
| Common Stock Issuance | $187,000 | $267,726 |
| Other | ||
| Repayment Of Debt | $-14,846 | $-43,884 |
| Issuance Of Debt | $141,554 | $33,646 |
| Interest Paid Supplemental Data | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 |
| End Cash Position | $8,016 | $25,300 |
| Beginning Cash Position | $25,300 | $12,196 |
| Effect Of Exchange Rate Changes | $95,576 | $-38,313 |
| Changes In Cash | $-112,860 | $51,417 |
| Net Issuance Payments Of Debt | $126,708 | $-10,238 |
| Net Long Term Debt Issuance | $126,708 | $-10,238 |
| Long Term Debt Payments | $-14,846 | $-43,884 |
| Long Term Debt Issuance | $141,554 | $33,646 |
| Change In Working Capital | $242,675 | $-89,691 |
| Change In Payables And Accrued Expense | $95,848 | $254,041 |
| Change In Payable | $95,848 | $254,041 |
| Change In Account Payable | $65,439 | $147,658 |
| Change In Prepaid Assets | $146,920 | $-343,737 |
| Change In Receivables | $-93 | $5 |
| Changes In Account Receivables | $-93 | $5 |
| Other Non Cash Items | $421,882 | $1,396,652 |
| Gain Loss On Investment Securities | $-215,620 | $3,257,122 |
| Net Income From Continuing Operations | $-875,505 | $-4,532,224 |
| Net Short Term Debt Issuance | - | $-10,238 |
| Short Term Debt Payments | - | $-43,884 |
| Short Term Debt Issuance | - | $33,646 |
| Asset Impairment Charge | - | $0 |
Fetched: 2026-02-02